Change in N-terminal-pro-B-type-natriuretic-peptide and the risk of sudden death, stroke, myocardial infarction, and all-cause mortality in diabetic dialysis patients.
about
Cardiopulmonary laboratory biomarkers in the evaluation of acute dyspneaInterpretation and use of natriuretic peptides in non-congestive heart failure settingsTemporal trajectory of B-type natriuretic peptide in patients with CKD stages 3 and 4, dialysis, and kidney transplant.Natriuretic Peptides as Biomarkers for Congestive States: The Cardiorenal Divergence.Biomarkers in predicting mortality and treatment in hemodialysis patientsTroponin I and NT-proBNP and the association of systolic blood pressure with outcomes in incident hemodialysis patients: the Choices for Healthy Outcomes in Caring for ESRD (CHOICE) StudyHomoarginine, heart failure, and sudden cardiac death in haemodialysis patients.B-type natriuretic peptide-guided therapy for perioperative medicine?Copeptin levels associate with cardiovascular events in patients with ESRD and type 2 diabetes mellitus.N-terminal pro-B-type natriuretic peptide variability in stable dialysis patientsAssociation of NTproBNP and cTnI with outpatient sudden cardiac death in hemodialysis patients: the Choices for Healthy Outcomes in Caring for ESRD (CHOICE) studyTroponin T, N-terminal pro-B-type natriuretic peptide, and incidence of stroke: the atherosclerosis risk in communities study.Mid-term Risk Stratification of Patients with a Myocardial Infarction and Atrial Fibrillation: Beyond GRACE and CHADSBrain natriuretic peptide for the prediction of sudden cardiac death and ventricular arrhythmias: a meta-analysis.Sudden cardiac death in patients with chronic kidney disease: prevention is the sine qua non.Clinical usefulness of novel prognostic biomarkers in patients on hemodialysis.Clinical utility of natriuretic peptides in dialysis patients.The diagnostic utility of cardiac biomarkers in dialysis patients.Cardiothoracic Ratio as a Predictor of Cardiovascular Events in a Cohort of Hemodialysis Patients.Utility of point-of-care testing of natriuretic peptides (brain natriuretic peptide and n-terminal pro-brain natriuretic peptide) in the emergency department.Vasoactive Peptide Levels after Change of Dialysis Mode.Efficacy of N-terminal pro-brain natriuretic peptide digit number for screening of cardiac disease in new haemodialysis patients.Diagnostic value of B-type natriuretic peptide for estimating left atrial size and its usefulness for predicting all-cause mortality and cardiovascular events among chronic haemodialysis patients.N-terminal-pro-B-type-natriuretic peptide associated with 2-year mortality from both cardiovascular and non-cardiovascular origins in prevalent chronic hemodialysis patients.Japanese Society for Dialysis Therapy guidelines for management of cardiovascular diseases in patients on chronic hemodialysis.Increasing B-type natriuretic peptide levels predict mortality in unselected haemodialysis patients.Prediction of sudden death in elderly patients with heart failure.Chronic kidney disease and arrhythmias: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference
P2860
Q26745756-187FAD42-0B0C-40BC-80BC-C7BB39DB91D0Q33670478-86B3525A-2F17-4029-94E1-AE866E53723CQ33715796-0881D8D8-34E1-43B2-908A-13E8514A31AAQ33862358-1CA3EC6C-C183-4CCF-8815-00224ECCBE42Q34062442-11DC00E9-AD5B-409C-AFD2-9D728D21A135Q34084375-9412F054-7620-453E-ADAD-1124940F12FEQ34203721-E30BB6BB-14C7-4CF1-8F4A-404403EB7A2DQ34304406-BA16C170-94D5-4230-93F9-8E03A38773A0Q34726918-080D4FA3-C563-45C9-957E-9D509D88436AQ35278624-50F284F4-A65D-47A6-B3D1-18575943AEB4Q35929287-8656024C-433A-4717-BA7A-5C18BBC061BAQ36733964-30F41A20-72D3-464B-940B-E99305E90863Q37496035-3A5E24B1-7868-4218-A0E6-3871063E5064Q37605486-FA46AE1A-D94F-4C3F-BE3B-046EF3A94345Q37892314-A7A88E2C-C1A2-4D7D-88C2-0A0D23F2E484Q37951798-C5DCEBE8-60BF-4A81-B509-5F26167B8580Q38011232-546A5B1E-21C6-4944-A9D5-3BEB4CCE8D12Q38022786-76566B54-3C03-4C56-9C2A-CF2E26C276E1Q41918048-DBAEAC52-9E36-41ED-BB22-0BF5E1CBF3AFQ42563345-686C4B5C-BD7A-4DCC-B506-70492E02788EQ42635538-39520486-D9FB-425B-AFB3-ED54B8332BA2Q45536640-7233DFB9-A8A2-4337-AD7B-8E3A0A5798B3Q47441254-40F8A8D6-17E6-46CF-BDC3-BA1096DF2018Q49853451-208063F7-E3E6-491D-A027-DE0C74DEFA36Q50502242-3A795263-8DF6-4C27-A7D6-C064BC358169Q51164674-AC8AEC7F-C3A3-4615-83FB-068F653F41E3Q52584402-84A6BD32-68B4-41CF-9258-93D27E434281Q57750151-CE7A37DA-5D3F-4BF0-BFB6-27BBD6A360D0
P2860
Change in N-terminal-pro-B-type-natriuretic-peptide and the risk of sudden death, stroke, myocardial infarction, and all-cause mortality in diabetic dialysis patients.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
Change in N-terminal-pro-B-typ ...... in diabetic dialysis patients.
@en
type
label
Change in N-terminal-pro-B-typ ...... in diabetic dialysis patients.
@en
prefLabel
Change in N-terminal-pro-B-typ ...... in diabetic dialysis patients.
@en
P2093
P2860
P356
P1476
Change in N-terminal-pro-B-typ ...... in diabetic dialysis patients.
@en
P2093
Christiane Drechsler
Christoph Wanner
German Diabetes and Dialysis Study Investigators
Jürgen Lilienthal
Karl Winkler
Vera Krane
P2860
P304
P356
10.1093/EURHEARTJ/EHN278
P577
2008-07-09T00:00:00Z